De nouvelles publications académiques sont ajoutées chaque semaine pour les universités, bibliothèques, chercheurs et distributeurs spécialisés.

Biotechnologie Vol. 9: Diseases et Theranostics

Biotechnologie et Génétique Ingénierie

Biotechnologie Vol. 9: Diseases et Theranostics

Par Guest Ed. Surender Singh

US $ 135.00 Envoyer une demande
ISBN 13
9781626990241
ISBN 10
1626990247
Éditeur
SP LLC, USA
Année
2014
Pages
Reliure
HB

Description

"With le increased understanding de drug mechanisms et disease manifestations, escalated headway en clinical research, et breakthrough pharmaceutical technologies, an unparallel interest has been witnessed towards le realm de novel drug delivery systems. These drug delivery systems have been instrumental en bringing revolutionary changes en le treatment options et le health scenario across le globe. Likewise, le future is primed to unfold an epoch driven by a fusion de biotechnology et nanotechnology, as many drug products oriented sur these cutting-edge technologies are already en le pipeline de approval by various key regulatory agencies. Accordingly, it has almost become mandatory pour every health professional, pharmaceutical scientist, biotechnologist et nanotechnologist to have le requisite perception de various newer drug delivery systems. Le current volume 8 de 12 volume series is a compilation de diverse novel approaches to strategically deliver le drugs to le desired site at le desired rate et concentration. Le volume 8 involves discussion sur le following topics: • Recent developments en drug delivery systems • Cyclodextrin nanoformulations as drug carriers pour treatment de skin pathologies • Challenges et opportunities en pulmonary drug delivery • Targeted drug delivery pour treatment de periodontal diseases • Sonoporation as a new approach to gene therapy • Janus particles pour biomedical et drug delivery applications • Novel approaches pour colon drug delivery • Ionic liquids as promising pharmaceutical carriers en drug delivery • Novel drug delivery vehicles pour colloidal drug delivery • Carbon nanotubes et their drug delivery applications • Properties et applications de cell permeable peptides • Formulation, application et scientific validation de herbosomes • Développement de implantable drug delivery systems • Micronized ethylcellulose pour oral modified-release drug delivery systems • Chitosan-based drug delivery systems • Traditional foods as delivery vehicles pour probiotics et nutraceuticals • Role de en vitro/in vivo correlation en product development et biowaivers de drug delivery systems • Recent developments en mouth dissolving tablets formulations et designs Le volume 8 contains 18 chapters from 63 researchers and/or academicians representing 6 nations, namely Inde, Japan, Nigeria, Romania, Taiwan ROC et United States de America giving an overview de le various research activities being carried out en different parts de le world en le area de Novel Drug Delivery. "

Table des matières

Foreword to le Series; À propos de le Editors; List de Contributors; À propos de le Series; Preface; Biomarkers de Diabetes: Diagnostic et Therapeutic Approchees; Recent Développements en Pharmaceutical Biotechnologie pour Critical Care: Angiopoietins pour le Diagnosis et Treatment de Sepsis; Factors Influencing Association pour Risk en Various Cancers; Targeting Tumor Microenvironment: Ultimate Therapy de Cancer; Bacteria en Cancer Therapeutics; Chemokines et Chemokine Receptors en Urological Cancer Susceptibility; Potential de Epithelial-Mesenchymal Transition en Diagnosis et Treatment de Solid Cancer; Moléculaire Imaging en Preclinical Cancer Recherche; Fetal Stem Cells Amniotic Membrane: Le Future de Regenerative Medicine; Le Cell Therapy as Alternative to Cure Diseases - Un Necessary Reality: Literature Review; Vector-Borne Diseases; Bacterial, Protozoan et Viral Life-Threatening Diseases; Fungal Infections: Diagnosis et Treatment; Drug Resistant Bacterial Infections – Diagnosis et Treatment; Hepatitis B Virus et Its Gestion; Antimicrobial Potential de Natural Phenolic Compounds Against Human Pathogens; RNUn Interference as a Therapeutic Strategy Against Viral Diseases; Immobilized Enzymes as Tool pour Diagnostics et Therapeutics pour Variety de Human Diseases; Current Diagnosis et Treatment de Acute Ischemic Stroke; Leishmaniasis: Trypanothione Metabolism as Potential Drug Targets pour Rational Drug Conceptioning; Energetic Levels de Metabolic Pathways en Malignant B et T Cells Mini-review; Autoimmune Antiphospholipid Antibody Syndrome en Pregnancy Complications; Appendix-I: Table de Contents de Biotechnologie Series Vols. (1 to 12); Subject Index.